medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2009, Número 587

<< Anterior Siguiente >>

Rev Med Cos Cen 2009; 66 (587)


Mononucleosis infecciosa

Lara VHP

Idioma: Español
Referencias bibliográficas: 20
Paginas: 73-77
Archivo PDF: 222.32 Kb.


RESUMEN

La mononucleosis infecciosa es un síndrome clínico causado por el virus Epstein-Barr. Aunque la mayoría de las infecciones por EBV en niños son asintomáticas o tienen síntomas inespecíficos, las infecciones en adolescentes y adultos frecuentemente resultan en mononucleosis infecciosa, con sus síntomas clásicos ya descritos. El tratamiento se basa en medidas de soporte.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Ambinder R, Lin L. Mononucleosis in the Laboratory. JID 2005; 192: 1503-4.

  2. Bottieau E et al . Infectious Mononuc leosis-Like Syndromes en Febrile Travelers Returning From the Tropics. Journal of Travel Medicine 2006; 13: 191-97.

  3. Chapman A, Watkin R, Ellis C. Lesson of the Week: Abdominal Pain in Acute Infectious Mononucleosis. BMJ 2002; 324: 660-661.

  4. Cohen J. Epstein-Barr Virus Infection. NEJM 2000; 343: 481-89.

  5. Crawford D et al. Sexual History and Epstein-Barr Virus Infection. JID 2002; 186: 731-6.

  6. Duca K et al. A Virtual Look at Epstein-Barr Virus Infection: Biological Interpretations. Plos Pathogens 2007; 3: e137. doi:10.1371/journal.ppat.0030137.

  7. Ebell M. Epstein-Barr Virus Infectious Mononucleosis. American Family Physician 2004; 40: 1279-87.

  8. Fachiroh J et al. Molecular Diversity of Epstein-Barr Virus IgG and IgA Antibody Responses in Nasopharyngeal Carcinoma: A Comparison of Indonesian, Chinese, and European Subjects. JID 2004; 190: 53-62.

  9. Fafi-Kremer S et al. Long-Term Shedding of Infectious Epstein-Barr Virus After Infectious Mononucleosis. JID 2005; 191: 985-9.

  10. Farrel P. Role for HLA in Susceptibility to Infectious Mononucleosis. J. Clin. Invest 2007; 117: 2756-2758.

  11. Higgins C et al. A Study of Risk Factors for Adquisition of Epstein-Barr Virus and Its Subtypes. JID 2007; 195: 474-82.

  12. Lawee D. Mild Infectious Mononucleosis Presenting with Transient Mixed Liver Disease. Canadian Family Physician 2007; 53: 1314-16.

  13. Macsween K, Crawford D. Epstein-Barr – Recent Advances. The Lancet Infectious Diseases 2003; 3: 131-38.

  14. Moss D, Suhrbier A, Elliott S. Candidate Vaccines for Epstein-Barr Virus. BMJ 1998; 317: 423-24.

  15. Seok I. Proteinuria in a Boy with Infectious Mononucleosis, C1q Nephropathy and Dent’s Disease. J Korean Med Sci 2007; 22: 928-31.

  16. Sitki-Green D et al. Biology of Epstein-Barr Virus During Infectious Mononucleosis. JID 2004; 189: 483-92.

  17. Stephenson J, DuBois J. Nonoperative Management of Spontaneous Splenic Rupture in Infectious Mononucleosis: A Case Report and Review of the Literature. Pediatrics 2007; 120: e432-e435.

  18. Taga K, Tosato G. Diagnosis of Atypical Cases of Infectious Mononucleosis. CID 2001; 33: 83-8.

  19. Taylor G. Cytomegalovirus. American Family Physician 2003; 67: 519-24.

  20. Zanghellini F et al. AsymptomaticPrimary Cytomegalovirus Infection: Virologic and Immunologic Features. JID 1999; 180: 702-7.




2020     |     www.medigraphic.com